Sipa1l1 Is an Early Biomarker of Liver Fibrosis in CCl4-treated Rats

Biology Open - United Kingdom
doi 10.1242/bio.018887
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Company of Biologists

Related search

Natural Polyphenols Target the TGF-β/caspase-3 Signaling Pathway in CCl4-induced Liver Fibrosis in Rats

Journal of advanced Biomedical and Pharmaceutical Sciences
2019English

Is Endocan a Novel Potential Biomarker of Liver Steatosis and Fibrosis?

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2019English

Vitronectins Produced by Human Cirrhotic Liver and CCl4 -Treated Rats Differ in Their Glycosylation Pattern and Tissue Remodeling Activity

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2019English

The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice

PLoS ONE
Multidisciplinary
2016English

Genome‑wide Identification of Long Noncoding RNAs in CCl4‑induced Liver Fibrosis via RNA Sequencing

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Hepatoprotective Activity of Trapa Acornis Shell Extracts Against CCl4-induced Liver Injury in Rats

African Journal of Pharmacy and Pharmacology
2012English

Circulating microRNA-196a Is an Early Gastric Cancer Biomarker

Oncotarget
Oncology
2017English

Retracted: Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats With CCl4-Induced Liver Cirrhosis

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2017English

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

Stem Cells International
Cell BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy